{"id":224251,"date":"2024-06-26T00:00:00","date_gmt":"2024-06-26T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47041121-medtech-interventional-oncology-devices-market-insights\/"},"modified":"2026-03-31T10:11:02","modified_gmt":"2026-03-31T10:11:02","slug":"47042156-medtech-interventional-oncology-devices-market-insights-japan","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042156-medtech-interventional-oncology-devices-market-insights-japan\/","title":{"rendered":"Interventional Oncology Devices &#8211; Market Insights &#8211; Japan"},"content":{"rendered":"<p>Although the interventional oncology procedure volumes are increasing <span>marginally<\/span> in Japan, the Japanese interventional oncology device market will <span>decline<\/span> due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines, stringent device approval process, biennial reimbursement cuts, declining overall population, and increasing developments in anticancer drugs.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Japan from 2019 to 2033.<\/p>\n<p class=\"question-statement\"><strong>Clinical guidelines influence the adoption of interventional oncology devices in Japan.<\/strong><\/p>\n<p class=\"question-statement\">Which devices are favored by the clinical guidelines?<\/p>\n<p class=\"question-statement\">What are the recent revisions in the clinical guidelines, and how will they impact the adoption of various devices in the Japanese market?<\/p>\n<p class=\"question-statement\">How the revision in the clinical guidelines will impact the competitors in the market?<\/p>\n<p class=\"question-statement\"><strong>Reimbursement will be an important factor in the adoption of interventional oncology procedures in Japan.<\/strong><\/p>\n<p>What is the reimbursement scenario in the country, and how will it impact the adoption of interventional oncology devices in this market?<\/p>\n<p>Which devices are most impacted by the biennial reimbursement cuts in this market?<\/p>\n<p><strong>Positive clinical data will play an important role in driving the adoption of interventional oncology devices.<\/strong><\/p>\n<p>Which clinical trials were recently conducted in this market?<\/p>\n<p>What is the expected impact of these clinical trials on the market dynamics and device adoption?<\/p>\n<p><strong>Stringent regulatory framework and device approval delays will impact the interventional oncology device market in Japan.<\/strong><\/p>\n<p>How have regulatory approval delays impacted the Japanese interventional oncology device market?<\/p>\n<p>Which devices are anticipated to enter the Japanese market within the forecast period?<\/p>\n<p><strong>Market dynamics will change over the forecast period with anticipated entry of novel devices in this market.<\/strong><\/p>\n<p>What are the recent developments in the <abbr title=\"Irreversible Electroporation\">IRE<\/abbr> device and radioembolization sphere spaces, and how have those developments impacted estimated launch of these products?<\/p>\n","protected":false},"template":"","class_list":["post-224251","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-interventional-oncology-devices","medtech-therapy-area-other-medical-technology","medtech-geography-japan","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224251\/revisions"}],"predecessor-version":[{"id":294332,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224251\/revisions\/294332"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=224251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}